Alex Pasteur is a Partner at F-Prime Capital Partners, a position held since October 2012. In addition to this role, Alex serves as a Non Executive Director for multiple companies including Oviva, ARTBIO, Tenpoint Therapeutics, Ltd., NodThera, Genomics, Peptone, and Pulmocide, as well as for Shift Bioscience. Alex also holds a position as a Board Observer at Castor. Academic qualifications include a PhD in Chemistry and a Master of Arts in Natural Sciences, both obtained from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices